US EditionBiologists Pinpoint Novel Targets for Pancreatic Cancer Therapies
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Biologists Pinpoint Novel Targets for Pancreatic Cancer Therapies
In a groundbreaking advancement poised to reshape pancreatic cancer therapeutics, researchers at the Massachusetts Institute of Technology (MIT) and the Dana-Farber Cancer Institute have uncovered a novel class of peptides uniquely expressed by pancreatic tumor cells. These peptides, termed cryptic peptides, arise from genomic sequences previously deemed non-coding, ushering in an unexpected frontier for T cell-mediated immunotherapy against one…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
